Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Camlin Fine Sciences Ltd

| Q2 and H1 FY26 Earnings Call

NEUTRAL SENTIMENT

Report Source

⬤10th Nov 25

Summary : Camlin Fine Sciences reported Q2 revenue growth driven by blends and straights, but faces tariff and competition pressures on realizations, while pursuing strategic acquisitions and salesforce expansion for future growth.

Management Perspective positive : Management expressed confidence in achieving growth targets for blends and Vanillin, despite current market pressures. They highlighted strategic hires and acquisitions as drivers for future growth, stating they are 'on track for the growth'.

Concall Report Analysis & Insights

Business Overview

  1. Q2 revenue grew 8.6% QoQ to Rs. 460 crores, driven by increased trades and blends.
  2. Blends business grew 8% with improved gross margins of 46%, supported by increased marketing staff.
  3. Aroma volumes increased, but net realization was subdued due to tariff situations.
  4. Straights business (TBHQ, BHA) saw 40% volume growth QoQ, recovering from a prior shutdown.
  5. Vanillin volumes increased 35% QoQ, but realizations faced pressure from 50% tariffs on US exports.

Future Growth Prospects

  1. Blends business is projected to grow 18-20% year-on-year, supported by increased salesforce and inorganic growth.
  2. New acquisition in France (Vinpai) is expected to become a subsidiary this quarter, adding revenue.
  3. Management targets 2,500 tons for Vanillin sales this year and 4,000 tons for next year.
  4. Diphenol facility is at 50-55% utilization, with full capacity expected to yield significant EBITDA improvement.
  5. Expanded field force for blends (31 new hires) is expected to show results from Q4 onwards.

Management Insights

  1. The company is on a growth path despite tariff and realization challenges, expecting improvement as the year progresses.
  2. Gross margins improved to 46% due to optimum capacity utilization at Tarapur and Dahej plants.
  3. Employee costs increased due to strengthening the blends marketing team across US, Brazil, Europe, and India.
  4. Net debt remained stable at Rs. 520 crores, with growth debt expected to stay at current levels.
  5. Management is confident in achieving FY'26 sales guidance of Rs. 2,000-2,100 crores.

Signs of Skepticism

  1. Delay in Vanillin channel de-stocking completion in the US and Europe compared to previous expectations.
  2. Uncertainty regarding the full impact and timing of realization improvement if US tariffs are reduced.
  3. The impact of Syensqo restarting its synthetic Vanillin unit on European sales volumes.

Risk Factors

  1. Realization pressure in Aroma and Straights businesses due to tariffs and heightened local competition.
  2. 50% tariff on Indian Vanillin exports to the US impacts net realization and margins.
  3. Channel de-stocking for Vanillin in Europe is expected to continue until Q1 FY'27.
  4. Discontinued European diphenol operations incur a quarterly hit of Rs. 5-6 crores.
  5. Chinese competitors are selling Vanillin at very low prices ($7-$7.5) in some markets.

Good To Know

  1. Q2 EBITDA was Rs. 33 crores (7.27%), an increase from Rs. 19 crores last quarter.
  2. Gross debt is stable at Rs. 640-645 crores; net debt is Rs. 520 crores.
  3. Vinpai acquisition is expected to be consolidated by November end, with a current monthly run rate of €1 million+.
  4. Discontinued China business liquidation proceedings initiated, aiming for no costs from FY'27.
  5. Vanillin plant is operating at 50-60% capacity, with incremental sales offering good margins.

Key Drivers

  1. New acquisition to boost revenue.
  2. Blends business growth at 18-20%.
  3. Increased Vanillin sales volumes.
  4. Diphenol facility capacity ramp-up.

Key Analyst Discussions

Competitive Environment

  1. Analysts asked about the impact of local competition on TBHQ and BHA pricing.
  2. Questions regarding the effect of Syensqo restarting its synthetic Vanillin unit in France on European sales.
  3. Discussion on Chinese competitors selling Vanillin at lower prices ($7-$7.5) in some markets.

Market Trends & Consumer Behavior

  1. Questions about the current state of Vanillin channel inventory in the US and Europe.
  2. Inquiries about the slowdown in the US pet food business and its recovery.
  3. Discussion on the overall demand trend for Vanillin in non-US, non-Europe markets.
  4. Questions about the current Vanillin pricing trends observed in October and November.

Financial Highlights

  1. Analysts questioned the 200 bps decline in gross margin year-on-year despite sales improvement.
  2. Queries on current Vanillin retail prices in the US ($19-$20) and net realization ($11-$12).
  3. Discussion on the impact of tariff reduction on net realization and the delay in its full effect.
  4. Questions about the current utilization rate and incremental EBITDA from the commercialized diphenol facility.
  5. Guidance for next year's Vanillin sales (4,000 tons) and Blends growth (20%) was provided.

Product Composition

  1. Analysts asked about the strategy for Vanillin sales mix between US and Europe given tariff uncertainties.
  2. Questions regarding the sales force expansion and whether they sell the entire product basket, including Vinpai products.

Strategic Considerations

  1. Questions about the timeline for Vinpai acquisition integration and consolidation.
  2. Inquiries about plans for the European discontinued business and timeline for loss reduction.
  3. Discussion on the strategy to increase Vanillin production and volumes once channel stocks clear.
  4. Questions about the company's approach to signing short-term vs. long-term contracts for Vanillin.